• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于砜类CRTh2拮抗剂的构效关系(SAR)和构动关系(SKR)

Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of sulphone-based CRTh2 antagonists.

作者信息

Buil Maria Antonia, Calbet Marta, Castillo Marcos, Castro Jordi, Esteve Cristina, Ferrer Manel, Forns Pilar, González Jacob, López Sara, Roberts Richard S, Sevilla Sara, Vidal Bernat, Vidal Laura, Vilaseca Pere

机构信息

Almirall R&D Centre, Laureano Miró, 408-410, 08980, Sant Feliu de Llobregat, Barcelona, Spain.

Almirall-Barcelona Science Park Unit, Barcelona Science Park, Josep Samitier 1-5, 08028 Barcelona, Spain.

出版信息

Eur J Med Chem. 2016 May 4;113:102-33. doi: 10.1016/j.ejmech.2016.02.023. Epub 2016 Feb 11.

DOI:10.1016/j.ejmech.2016.02.023
PMID:26922232
Abstract

Monocyclic and bicyclic ring systems were investigated as the "core" section of a series of diphenylsulphone-containing acetic acid CRTh2 receptor antagonists. A range of potencies were observed and single-digit nanomolar potencies were obtained in both the monocyclic and bicyclic cores. Residence times for the monocyclic compounds were very short. Some of the bicyclic cores displayed better residence times. A methyl group in the northern part of the core, between the head and tail was a necessary requirement for the beginnings of long residence times. Variations of the tail substitution maximised potencies and residence times.

摘要

研究了单环和双环环系作为一系列含二苯砜乙酸CRTh2受体拮抗剂的“核心”部分。观察到一系列的活性,单环和双环核心均获得了个位数纳摩尔的活性。单环化合物的驻留时间非常短。一些双环核心表现出更好的驻留时间。核心北部、头部和尾部之间的甲基是长驻留时间开始的必要条件。尾部取代的变化使活性和驻留时间最大化。

相似文献

1
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of sulphone-based CRTh2 antagonists.基于砜类CRTh2拮抗剂的构效关系(SAR)和构动关系(SKR)
Eur J Med Chem. 2016 May 4;113:102-33. doi: 10.1016/j.ejmech.2016.02.023. Epub 2016 Feb 11.
2
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists II: lead optimization.双环杂芳基乙酸作为强效CRTh2拮抗剂的构效关系(SAR)和构动关系(SKR)II:先导化合物优化
Bioorg Med Chem Lett. 2014 Nov 1;24(21):5123-6. doi: 10.1016/j.bmcl.2014.08.029. Epub 2014 Aug 19.
3
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists I.双环杂芳基乙酸作为强效CRTh2拮抗剂的构效关系(SAR)和构动关系(SKR)I
Bioorg Med Chem Lett. 2014 Nov 1;24(21):5118-22. doi: 10.1016/j.bmcl.2014.09.005. Epub 2014 Oct 15.
4
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists III: the role of a hydrogen-bond acceptor in long receptor residence times.双环杂芳基乙酸作为强效CRTh2拮抗剂的构效关系(SAR)和构动关系(SKR)III:氢键受体在长受体驻留时间中的作用
Bioorg Med Chem Lett. 2014 Nov 1;24(21):5127-33. doi: 10.1016/j.bmcl.2014.08.028. Epub 2014 Aug 19.
5
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of pyrrolopiperidinone acetic acids as CRTh2 antagonists.作为CRTh2拮抗剂的吡咯并哌啶酮乙酸的构效关系(SAR)和构动关系(SKR)
Bioorg Med Chem Lett. 2014 Nov 1;24(21):5111-7. doi: 10.1016/j.bmcl.2014.08.026. Epub 2014 Aug 18.
6
Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2.前列腺素D2受体CRTH2的吲哚-3-乙酸拮抗剂
J Med Chem. 2005 Oct 6;48(20):6174-7. doi: 10.1021/jm050519b.
7
Isoquinoline derivatives as potent CRTH2 antagonists: design, synthesis and SAR.异喹啉衍生物作为强效 CRTH2 拮抗剂:设计、合成与 SAR 研究。
Bioorg Med Chem. 2013 Dec 15;21(24):7674-85. doi: 10.1016/j.bmc.2013.10.025. Epub 2013 Oct 30.
8
2-(1H-Pyrazol-1-yl)acetic acids as chemoattractant receptor-homologous molecule expressed on Th2 lymphocytes (CRTh2) antagonists.2-(1H-吡唑-1-基)乙酸作为 Th2 淋巴细胞表达的趋化因子受体同源物分子 (CRTh2) 拮抗剂。
Eur J Med Chem. 2014 Jan;71:168-84. doi: 10.1016/j.ejmech.2013.10.072. Epub 2013 Nov 9.
9
The synthesis of 2,3,6-trisubstituted 1-oxo-1,2-dihydroisoquinolines as potent CRTh antagonists.作为有效的CRTh拮抗剂的2,3,6-三取代-1-氧代-1,2-二氢异喹啉的合成。
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5344-5348. doi: 10.1016/j.bmcl.2017.07.064. Epub 2017 Jul 25.
10
Evolution of novel tricyclic CRTh2 receptor antagonists from a (E)-2-cyano-3-(1H-indol-3-yl)acrylamide scaffold.从(E)-2-氰基-3-(1H-吲哚-3-基)丙烯酰胺支架上开发新型三环 CRTh2 受体拮抗剂的进展。
Bioorg Med Chem Lett. 2013 Feb 15;23(4):944-8. doi: 10.1016/j.bmcl.2012.12.050. Epub 2012 Dec 25.

引用本文的文献

1
Indole-Based and Cyclopentenylindole-Based Analogues Containing Fluorine Group as Potential F-Labeled Positron Emission Tomography (PET) G-Protein Coupled Receptor 44 (GPR44) Tracers.含氟基团的基于吲哚和环戊烯基吲哚的类似物作为潜在的F标记正电子发射断层扫描(PET)G蛋白偶联受体44(GPR44)示踪剂
Pharmaceuticals (Basel). 2023 Aug 24;16(9):1203. doi: 10.3390/ph16091203.
2
Synthesis of imidazo[1,5-]pyridines via cyclocondensation of 2-(aminomethyl)pyridines with electrophilically activated nitroalkanes.通过2-(氨基甲基)吡啶与亲电活化的硝基烷烃的环缩合反应合成咪唑并[1,5 -]吡啶。
Beilstein J Org Chem. 2020 Nov 26;16:2903-2910. doi: 10.3762/bjoc.16.239. eCollection 2020.
3
Binding kinetics of ligands acting at GPCRs.
作用于 G 蛋白偶联受体的配体的结合动力学。
Mol Cell Endocrinol. 2019 Apr 5;485:9-19. doi: 10.1016/j.mce.2019.01.018. Epub 2019 Feb 8.